Arrowhead pharmaceuticals, inc. (ARWR)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Jun'10
REVENUE

138,972

163,592

168,795

136,757

94,788

47,290

16,142

13,601

22,216

30,552

31,407

22,725

13,422

4,480

158

170

255

255

382

382

302

302

175

175

175

175

290

290

294

281

146

103

55

23

296

0

0

0

-

OPERATING EXPENSES
Research and development

95,494

86,850

81,048

73,656

66,417

57,620

52,968

55,777

54,861

54,297

50,904

64,436

62,723

61,306

62,117

40,174

38,241

39,861

47,267

45,271

44,173

37,749

23,138

17,989

13,353

10,261

8,705

7,502

6,965

6,199

5,391

3,856

3,003

1,784

3,277

2,891

0

0

0

Acquired in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Salaries and payroll-related costs

-

-

-

-

-

-

-

-

-

-

-

-

-

19,817

-

18,573

18,030

17,323

16,554

15,458

14,341

13,898

12,829

9,295

8,492

7,120

6,667

6,428

6,431

6,723

6,414

5,313

4,012

2,421

1,408

1,168

0

0

0

General and administrative expenses

42,337

31,351

26,556

22,718

22,503

20,846

19,110

20,727

20,053

20,048

17,499

25,000

23,356

23,497

23,594

10,364

9,918

7,796

7,931

7,662

7,415

7,066

5,894

4,735

4,052

3,484

3,488

3,701

5,939

6,090

6,439

7,046

4,546

4,430

3,795

2,820

0

0

0

Stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

11,639

-

11,074

10,810

10,598

10,232

8,643

8,196

7,189

5,696

4,180

2,505

1,661

1,536

1,518

1,570

1,385

1,241

1,135

1,065

1,258

1,376

1,469

0

0

0

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

3,651

-

3,272

3,194

2,840

2,336

1,751

1,286

1,232

1,345

1,474

1,652

1,705

1,751

1,799

1,768

1,744

1,748

1,368

1,012

0

-

0

0

-

-

Contingent consideration - fair value adjustments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

Impairment expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Amortization of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

TOTAL OPERATING EXPENSES

137,832

118,201

107,604

96,374

88,920

78,467

72,078

68,618

67,028

66,459

68,403

71,265

75,590

81,783

81,901

85,350

82,087

90,454

96,355

93,478

90,104

71,684

53,451

39,096

32,785

26,963

24,879

22,258

22,676

22,142

21,236

18,726

13,645

10,557

10,126

8,605

0

0

0

OPERATING INCOME (LOSS)

1,139

45,390

61,190

40,383

5,868

-31,176

-55,936

-55,017

-44,811

-35,907

-36,995

-48,540

-62,168

-77,303

-81,742

-85,179

-81,832

-90,199

-95,973

-93,096

-89,802

-71,382

-53,276

-38,921

-32,610

-26,788

-24,589

-21,968

-22,381

-21,860

-21,089

-18,623

-13,590

-10,533

-9,830

-8,309

0

0

0

OTHER INCOME (EXPENSE)
Equity in income (loss) of unconsolidated affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-78

-329

-568

-716

-641

-415

-290

-197

-240

-272

-307

-318

-163

-162

0

0

0

Impairment on investment in unconsolidated affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

Gain on purchase of Roche Madison

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,576

0

0

0

-

-

-

-

-

Gain (loss) on sale of fixed asset, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19

19

19

-31

-58

-58

-98

-148

-76

-952

-946

0

-

0

0

-

-

-

-

-

-

Interest income (expense), net

8,564

8,046

6,957

5,120

3,693

1,975

1,048

795

613

553

415

317

220

190

265

344

473

592

729

856

921

842

645

356

82

-64

-97

-59

2

35

35

43

49

79

86

61

0

0

0

Realized and unrealized gain (loss) in marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-58

-556

-196

0

-

0

0

-

-

Change in value of derivatives

-

-

-

-

-

-

432

-197

-133

-142

890

985

809

1,206

-301

655

664

463

2,869

2,125

2,988

-131

-6,033

-11,228

-11,786

-8,864

-5,300

376

1,090

498

386

116

-425

600

1,133

2,795

0

0

0

Gain on sale of stock in subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

-

-

-

-

Other income (expense)

-

-

-

-

-

-

-

-

-

-

1,312

0

0

0

-

-

-

-

417

483

493

34

82

81

330

-1,025

-997

0

0

0

-

-

-

-

-

-

-

-

-

TOTAL OTHER INCOME (EXPENSE)

8,564

8,046

6,957

5,127

3,701

1,964

1,488

598

479

416

2,618

2,672

2,399

2,761

22

935

1,072

1,572

4,035

3,475

4,491

772

-5,443

-11,178

-12,040

-10,819

-7,113

-1,530

-3,179

-2,344

-1,021

-833

429

1,868

1,045

2,555

0

0

0

INCOME (LOSS) BEFORE INCOME TAXES

9,704

53,437

68,148

45,511

9,569

-29,211

-54,448

-54,418

-44,332

-35,490

-34,377

-45,867

-59,768

-74,542

-81,720

-84,244

-80,759

-88,627

-91,938

-89,620

-85,310

-70,609

-58,720

-50,099

-44,651

-37,608

-31,703

-23,498

-25,560

-24,204

-22,110

-19,456

-13,161

-8,665

-8,785

-5,754

0

0

0

Provision for income taxes

-

-

-

2

-

-

2

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

LOSS FROM CONTINUING OPERATIONS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-31,703

-23,498

-25,560

-24,204

-22,110

-19,456

-13,161

-8,665

-8,785

-5,754

0

0

0

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-0

-69

-201

1,373

605

0

0

0

Gain on disposal of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

NET LOSS FROM DISCONTINUED OPERATIONS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

-0

0

0

-0

-0

-69

3,717

5,292

4,524

0

0

0

NET LOSS

-

-

-

-

-

-

-

-

-

-

-

-45,870

-59,771

-74,544

-81,723

-84,246

-80,761

-88,630

-91,940

-89,625

-85,316

-70,614

-58,725

-50,099

-44,651

-37,608

-31,703

-23,499

-25,560

-24,204

-22,110

-19,456

-13,231

-4,947

-3,492

-1,229

0

0

0

Net loss attributable to non-controlling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-95

-208

-309

-450

-560

-734

-883

-950

-984

-868

-814

-771

-363

-505

0

0

0

NET INCOME (LOSS)

9,531

53,263

67,974

45,508

9,566

-29,214

-54,450

0

0

0

-

-

-

-

-

-

-

-

-

-89,625

-85,318

-70,577

-58,630

-49,891

-44,342

-37,157

-31,143

-22,764

-24,677

-23,254

-21,125

-18,588

-12,417

-4,176

-3,128

-723

0

0

0

NET LOSS PER SHARE - BASIC & DILUTED

-

-

-

-

-

-

-

-

-

-

-

-0.07

-0.08

-0.17

-0.35

-0.32

-0.35

-0.32

-0.41

-0.27

-0.51

-0.41

-0.44

-0.22

-0.31

-0.28

-0.33

-0.23

-0.41

-0.33

-

-0.71

-

-

-

-

-

-

-

Loss from continuing operations attributable to Arrowhead common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.50

-0.25

-

-0.24

-0.13

-

-

Income from discontinued operations attributable to Arrowhead common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

-

-0.01

0.53

-

-0.01

NET INCOME (LOSS) PER SHARE - BASIC

-0.20

-0.03

0.13

0.21

0.25

0.13

-0.11

-0.18

-0.18

-0.18

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.50

-0.25

-

-0.25

0.40

-

-0.01

Income (loss) from continuing operations attributable to Arrowhead common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.24

-0.11

-

-

Income (loss) from discontinued operations attributable to Arrowhead common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

0.48

-

-0.01

NET INCOME (LOSS) PER SHARE - DILUTED

-0.20

-0.03

0.11

0.21

0.24

0.13

-0.11

-0.18

-0.18

-0.18

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.25

0.37

-

-0.01

Weighted average shares outstanding - basic

101,653

97,090

95,252

94,935

94,155

91,091

88,004

87,634

84,083

74,831

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,182

7,180

-

64,579

Weighted average shares outstanding - diluted

101,653

97,090

101,873

98,884

98,082

95,590

88,004

87,634

84,083

74,831

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,182

7,891

-

64,579

Loss from continuing operations attributable to Arrowhead common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.42

-

Income from discontinued operations attributable to Arrowhead common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.22

-

Net loss attributable to Arrowhead shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.20

-

Weighted average shares outstanding - basic and diluted

-

-

-

-

-

-

-

-

-

-

-

74,772

74,629

71,444

64,908

59,966

59,779

59,548

59,528

59,492

55,719

54,692

53,736

51,931

44,321

37,741

39,299

26,134

16,461

14,113

12,495

11,238

10,663

10,121

-

-

-

7,177

-

OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX:
Foreign currency translation adjustments

-557

-151

-370

-99

-97

-67

-54

15

55

208

25

12

-90

-94

143

103

130

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

COMPREHENSIVE INCOME (LOSS)

8,974

53,112

67,604

45,408

9,469

-29,281

-54,505

-54,406

-44,278

-35,284

-34,354

-45,858

-59,862

-74,639

-81,579

-84,211

-80,638

-88,720

-92,077

-78,890

-76,894

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-